CoLucid in Talks with Partners for Novel Migraine Treatment
Link: http://www.medcitynews.com/2011/08/colucid-in-talks-with-partners-for-novel-migraine-treatment/
Link: http://www.medcitynews.com/2011/08/colucid-in-talks-with-partners-for-novel-migraine-treatment/
Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.